UBS raised the firm’s price target on Novartis to CHF 108 from CHF 104 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on NVS: Novartis Q1 Results Surge, 2024 Outlook Brightens Novartis FY24 net sales, core operating income guidance raised Novartis reports Q1 core EPS grew 23% in constant currency to $1.80 NVS Earnings: Novartis Beats Q1 Estimates, Raises Outlook VGK vs. EZU: Which Is the Better European Stock ETF?